Sakya Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.15 M
- Paid Up Capital ₹ 50.00 K
- Company Age 3 Year, 3 Months
About Sakya Pharma
Sakya Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 October 2021 (Three years and three months 12 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.15 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Vyran Raj, Muthamizhchelvan Veeramuthu, Thangarasu Selvan, and Two other members serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51100TN2021PTC147221
-
Company No.
147221
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Oct 2021
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sakya Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vyran Raj
|
Director | 21-Oct-2021 | Current |
Muthamizhchelvan Veeramuthu
|
Director | 21-Oct-2021 | Current |
|
Thangarasu Selvan
|
Director | 21-Oct-2021 | Current |
|
Murugan Velan
|
Director | 21-Oct-2021 | Current |
|
Ellan Anban
|
Director | 21-Oct-2021 | Current |
Financial Performance of Sakya Pharma.
Enhance accessibility to Sakya Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sakya Pharma?
Unlock access to Sakya Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sakya Agroeconomy Private LimitedVyran Raj and Thangarasu Selvan are mutual person
-
Sakya Travel & Tours Private Limited
Vyran Raj and Thangarasu Selvan are mutual person
-
Sakya Capital Limited
Vyran Raj, Thangarasu Selvan and 2 more are mutual person
-
Relineindia Private Limited
Vyran Raj is a mutual person
-
Sakya Chamber Of Commerce
Vyran Raj and Thangarasu Selvan are mutual person
-
Arirang Biotech Private Limited
Thangarasu Selvan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sakya Pharma?
Sakya Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sakya Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sakya Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.